Skip to main content
Neurology logoLink to Neurology
. 2019 May 7;92(19):e2298. doi: 10.1212/WNL.0000000000007463

Teaching Video NeuroImages: Opsoclonus in anti-DPPX encephalitis

Jonathan A Micieli 1,, Nancy J Newman 1, Carlos S Kase 1, Valérie Biousse 1
PMCID: PMC9289957  PMID: 31061220

A 49-year-old man presented with a 15-month history of binocular diplopia and oscillopsia and a 6-month history of headaches, memory loss, anorexia, myalgias, and unintentional 105-pound weight loss without diarrhea. Neuro-ophthalmic assessment revealed episodic bursts of opsoclonus, intermittent jerk nystagmus, saccadic pursuit, and slowed and dysmetric saccades, and he was unable to maintain fixation (video 1). Anti-DPPX antibodies were positive in the CSF. He was treated with IV methylprednisolone, plasmapheresis, and rituximab, and his ocular symptoms resolved several months after treatment. Opsoclonus is an ocular manifestation of anti-DPPX encephalitis, which may also cause nystagmus, skew deviation, and saccadic pursuit due to DPPX expression in the cerebellum.1,2

Video 1

Voluntary eye movements were slow and limited in all directions of gaze. The patient had saccadic pursuit, dysmetric saccades, and was unable to maintain fixation. He had episodic bursts of opsoclonus with jerk nystagmus. Six months after treatment, his eye movements were normal apart from a small amplitude gaze-evoked nystagmus.Download Supplementary Video 1 (13.3MB, mp4) via http://dx.doi.org/10.1212/007463_Video_1

Footnotes

Teaching slides links.lww.com/WNL/A875

Author contributions

J.A. Micieli: study conception and design, manuscript preparation. N.J. Newman: study conception and design, final approval of manuscript. C.S. Kase: study conception and design, final approval of manuscript. V. Biousse: study conception and design, final approval of manuscript.

Study funding

This study was supported in part by an unrestricted departmental grant (Department of Ophthalmology) from Research to Prevent Blindness, Inc., New York, and by NIH/NEI core grant P30-EY006360 (Department of Ophthalmology).

Disclosure

The authors report no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.

References

  • 1.Tobin WO, Lennon VA, Komorowski L, et al. DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology 2014;83:1797–1803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Balint B, Jarius S, Nagel S, et al. Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology 2014;82:1521–1528. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Video 1

Voluntary eye movements were slow and limited in all directions of gaze. The patient had saccadic pursuit, dysmetric saccades, and was unable to maintain fixation. He had episodic bursts of opsoclonus with jerk nystagmus. Six months after treatment, his eye movements were normal apart from a small amplitude gaze-evoked nystagmus.Download Supplementary Video 1 (13.3MB, mp4) via http://dx.doi.org/10.1212/007463_Video_1


Articles from Neurology are provided here courtesy of American Academy of Neurology

RESOURCES